The 5th EACTS Mechanical Circulatory Support Summit will be an in-person meeting and run from 4-6 November 2021 in Berlin, Germany.
THURSDAY 4 NOVEMBER (08:00-18:15)
| 08:00 | Welcome | J Gummert, Bad Oeynhausen; V Falk, Berlin; I Netuka, Prague; F Gustafsson, Copenhagen |
| 08:15 | Session 1: Current status of heart failure therapy | |
| Moderators: J Gummert, Bad Oeynhausen; F Gustafsson, Copenhagen | ||
| Heart failure therapy: Update on new drugs and devices | S Anker, Berlin | |
| Current organ allocation in Spain | D García-Cosio, Madrid | |
| Current organ allocation in Eurotransplant | F Schönrath, Berlin | |
| Current organ allocation in UNOS | C Mahr, Seattle | |
| SARS-CoV-2 myocarditis and the general impact of the pandemic on advanced heart failure therapy (MCS – HTX) | R Schramm, Bad Oeynhausen | |
| Short and long-term mechanical circulatory support: What are the challenges for the next decade? | M Mehra, Boston | |
| Panel discussion | ||
| 10:00 | Break | |
| 10:45 | Session 2: Update on guidelines and registries | |
| Moderators: M Morshuis, Bad Oeynhausen; E Potapov, Berlin | ||
| Proposal for short-term MCS guidelines | F Pappalardo, Alessandria | |
| Update on the ISHLT MCS guidelines | D Saeed, Leipzig | |
| Update on the ESC heart failure guidelines | T McDonagh, London | |
| EUROMACS report | T De By, Rotterdam | |
| Panel discussion | ||
| Featured lecture | A Meyer & F Köhler, Berlin | |
| 12:15 | Lunch | |
| 13:15 | Session 3: Paediatric MCS | |
| Moderators: M Hübler, Hamburg; E Sandica, Bad Oeynhausen | ||
| Perspectives of myocardial recovery in the paediatric population | O Miera, Berlin | |
| Challenges in long-term paediatric MCS: Differences to adult patients | M Hübler, Hamburg | |
| MCS or transplant | S Schubert, Bad Oeynhausen | |
| MCS in GUCH population: Surgical technical considerations | D Zimpfer, Vienna | |
| Panel discussion | ||
| 14:45 | Session 4: The perioperative setting | |
| Moderators: B O’Brien, Berlin; V Von Dossow, Bad Oeynhausen | ||
| Preimplant optimization | V Von Dossow, Bad Oeynhausen | |
| My approach is less invasive | J Schmitto, Hanover | |
| Sternotomy is my preferred access | M Morshuis, Bad Oeynhausen | |
| Is there a less invasive approach for off-pump LVAD implantation? | S Tsui, Cambridge | |
| On-pump LVAD implantation is my preferred approach | E Potapov, Berlin | |
| Panel discussion | ||
| 16:15 | Break | |
| 16:45 | Session 5: Rehabilitation after MCS | |
| Moderators: J Altenberger, Salzburg; C Hagl, Munich | ||
| Patient oriented rehabilitation in LVAD therapy | A Fründ, Bad Oeynhausen | |
| Nutritional and physical status in VAD candidates: Impact on long-term outcomes | J Stehlik, Salt Lake City | |
| Frailty in end-stage heart failure: Impact on long-term outcomes | L Röhrich, Berlin | |
| Psychological/social rehabilitation after VAD implantation | K Tigges-Limmer, Bad Oeynhausen | |
| Panel discussion | ||
| 18:15 | Close | |
| Welcome reception and poster session (18:15-19:30) | ||
| Moderators: A Bernhardt, Hamburg; S Günther, Bad Oeynhausen; J Mulzer, Berlin; A Uribarri, Pamplona |
FRIDAY 5 NOVEMBER (08:00-18:00)
| 08:00 | Session 6: Valvular disease in long-term MCS |
|
| Moderators: V Rudolph, Bad Oeynhausen; C Starck, Berlin | ||
| How to prevent secondary aortic valve regurgitation in LVAD patients | K Caliskan, Rotterdam | |
| Secondary aortic valve replacement in ongoing LVAD therapy: Indications and outcomes | S Rojas Hernandez, Bad Oeynhausen | |
| TAVR for secondary aortic valve regurgitation | J Knierim, Berlin | |
| Interventional mitral valve procedures on LVAD | V Rudolph, Bad Oeynhausen | |
| When to approach tricuspid valve regurgitaion at LVAD implantation | G Faerber, Jena | |
| Panel discussion | ||
| 09:30 | Session 7: Challenges in long-term support (Case oriented) |
|
| Moderators: F Gustafsson, Copenhagen; U Jorde, New York | ||
| Clinical course of COVID-19 in LVAD patients | D Lewin, Berlin | |
| Discussant | R Schramm, Bad Oeynhausen | |
| Device infections | S Günther, Bad Oeynhausen | |
| Discussant | To be announced | |
| Thromboembolic events | I Netuka, Prague | |
| Discussant | F Kaufmann, Berlin | |
| Graft occlusion | C Hörmandinger, Berlin | |
| Discussant | D Zimpfer, Vienna | |
| Right ventricular heart failure | M Strueber, Memphis | |
| Discussant | E Potapov, Berlin | |
| Management of implantable cardiac devices in LVAD patients | U Jorde, New York | |
| Discussant | C Sohns, Bad Oeynhausen | |
| Panel discussion | ||
| 10:40 | Break | |
| 11:00 | Session 8: Unusual cases and creative solutions | |
| Moderators: E Potapov, Berlin; S Rojas Hernandez, Bad Oeynhausen | ||
| Case presentation 1 | P Lanmüller, Berlin | |
| Case presentation 2 | M Morshuis, Bad Oeynhausen | |
| Case presentation 3 | A Bernhardt, Hamburg | |
| Case presentation 4 | I Netuka, Prague | |
| Case presentation 5 | D Zimpfer, Vienna | |
| Panel discussion | ||
| 12:15 | 5th Rising Stars Quiz | |
| 13:30 | Lunch | |
| 14:30 | Session 9: EACTS/EACTA LVAD Masterclass | |
| Moderators: V Falk, Berlin; V Von Dossow, Bad Oeynhausen | ||
| Management of severe acquired coagulopathy | A Koster, Bad Oeynhausen | |
| Optimized management for INTERMACS I patients | E de Waal, Utrecht | |
| Different surgical approaches – impliances for cardiac anesthesia | M Kukucka, Berlin | |
| Standardized transesophageal echocardiography for LVAD surgery | S Bouchez, Gent | |
| Panel discussion | ||
| 15:35 | Session 10: Long-term support | |
| Moderators: F Gustafsson, Copenhagen; R Schramm, Bad Oeynhausen | ||
| Cardiac comorbidity in LVAD patients and their influence on long-term outcomes | M Mehra, Boston | |
| Key to success in ultra long-term LVAD support: Ideal patient characteristics | U Jorde, New York | |
| Treatment of arrhythmias in LVAD patients | P Sommer, Bad Oeynhausen | |
| Will VAD therapy replace heart transplantation? | A Meyer, Heidelberg | |
| Panel discussion | ||
| 16:30 | Break | |
| 16:50 | Session 11: Short-term MCS and cardiogenic shock | |
| Moderators: B Meyns, Leuven; A Meyer, Heidelberg | ||
| Device selection | F Pappalardo, Alessandria | |
| Timing in short-term MCS: When is it too early, when is it too late? | R Natanov, Hanover | |
| Combined algorithm for implantation and weaning of temporary MCS | E Potapov, Berlin | |
| Transition from temporary to durable MCS | D Saeed, Leipzig | |
| Transplant following ECLS | A Eixerés, Madrid | |
| Panel discussion | ||
| 18:00 | Close |
SATURDAY 6 NOVEMBER (08:00-14:00)
| 08:00 | Session 12: Right ventricular heart failure |
|
| Moderators: E Potapov, Berlin; M Strueber, Memphis | ||
| Pathophysiolgy of right ventricular failure in LVAD therapy and patient selection for biventricular support | C Mahr, Seattle | |
| Less invasive implantation = less right ventricular failure? | F Pagani, Ann Arbor | |
| Extracorporeal RVAD in acute right ventricular failure | M Morshuis, Bad Oeynhausen | |
| Percutaneous RVAD in LVAD patients | R Natanov, Hanover | |
| Chronic right heart failure: Myth or reality | M Strueber, Memphis | |
| Panel discussion | ||
| 09:00 | Session 13: Joint EACTS/HFA heart failure session | |
| Moderators: S Anker, Berlin; J Gummert, Bad Oeynhausen; F Gustafsson, Copenhagen | ||
| When to refer the elective HF patient for LVAD evaluation: Why are we always late? | S Nalbantgil, Izmir | |
| How to set the right advanced HF team at an LVAD centre | J Gummert, Bad Oeynhausen | |
| Long-term LVAD recipients should be managed by cardiologists | ||
| PRO | F Gustafsson, Copenhagen | |
| CON | E Potapov, Berlin | |
| Panel discussion | ||
| 10:00 | Break | |
| 10:30 | Session 14: Challenges in ongoing VAD therapy – Different centre, different approach | |
| Moderators: I Netuka, Prague; S Rojas Hernandez, Bad Oeynhausen | ||
| Pump thrombosis: VAD exchange or lysis? | I Just-Lauer, Berlin | |
| Optimized heart failure therapy in VAD patients | F Gustafsson, Copenhagen | |
| Bacteriophages for the treatment of infections in cardiovascular surgery | J Gross, Rostock | |
| Bacteriophages in VAD related infections | E Rubalskii, Hanover | |
| Bacteriophages in VAD related infections | J Mulzer, Berlin | |
| Panel discussion | ||
| 11:30 | Session 15: Future of VAD management | |
| Moderators: K Caliskan, Rotterdam; H Fox, Bad Oeynhausen | ||
| The fully implantable device | I Netuka, Prague | |
| Discussant | M Morshuis, Bad Oeynhausen | |
| Indications and interactions with other medical devices | H Fox, Bad Oeynhausen | |
| Discussant | C Starck, Berlin | |
| Hemodynamic guidance with remote monitoring sensor for pulmonary pressure in VAD therapy | K Caliskan, Rotterdam | |
| Discussant | G Faerber, Jena | |
| Panel discussion | ||
| 12:30 | Session 16: Update of current and upcoming devices |
|
| Moderators: M Morshuis, Bad Oeynhausen; E Potapov, Berlin | ||
| Keynote lecture – Innovation in heart failure: From lumping to splitting | T Luescher, Zurich | |
| 13:00 | VAD Café: Ask the Industry | |
| 14:00 | Closing Remarks |
Programme and faculty subject to change
Summit INFORMATION
Date/Duration
4-6 November 2021 (2.5 day course)
Location
Crowne Plaza Berlin City Centre
Berlin, Germany
Chairmen
J Gummert, Bad Oeynhausen; V Falk, Berlin; I Netuka, Prague and F Gustafsson, Copenhagen
Registration Fee
EACTS Members: €550 inclusive of VAT
Non-Members: €650 inclusive of VAT
Registration fee includes lunch and refreshments on all days and the welcome reception on Thursday 4 November
Proof of full Covid-19 vaccination or a negative PCR test will be required for all attendees. Documentation will need to be shown before badge collection.
Summit Format
In-person meeting, interactive lectures, live-in-a-box cases and keynote presentations
Target Audience
Cardiologists, heart failure cardiologists, emergency and ICU specialists (ECLS), cardiac surgeons, perfusionists, heart failure nurses and ventricular assist device (VAD) coordinators, medical industry (cardiac devices including ECMO development and production). Paediatric cardiologists and congenital heart disease surgeon.
Abstracts
New to the programme, we will be holding a poster session which will take place in the Exhibition Area from 18:15-19:30 on the 4th November.
Please note abstract submission is now CLOSED.
Please click here for the EACTS Academy terms and conditions.
5th EACTS Mechanical Circulatory Support Summit, Berlin, Germany, 04/11/2021-06/11/2021
has been granted 18 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).
Faculty
-
Johann Altenberger -
Stefan Anker -
Alexander M. Bernhardt -
Kadir Caliskan -
Theo de By -
Eric de Waal -
Volkmar Falk -
Henrik Fox -
Andreas Fruend -
Dolores García-Cosio -
Justus Gross -
Jan Gummert -
Finn Gustafsson -
Christian Hagl -
Ulrich Jorde -
Isabell Just-Lauer -
Friedrich Kaufmann -
Jan Knierim -
Andreas Koster -
Thomas F. Lüscher -
Claudius Mahr -
Mandeep R. Mehra -
Bart Meyns -
Johanna Mulzer -
Ivan Netuka -
Benjamin O’Brien -
Federico Pappalardo -
Evgenij Potapov -
Luise Roehrich -
Sebastian Rojas Hernandez -
Diyar Saeed -
Jan Schmitto -
Felix Schönrath -
René Schramm -
Philipp Sommer -
Josef Stehlik -
Martin Strueber -
Aitor Uribarri -
Daniel Zimpfer
